TIDMAREC

RNS Number : 1449V

Arecor Therapeutics PLC

05 August 2022

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BMWLM973

Issuer Name

Arecor Therapeutics plc

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting

3. Details of person subject to the notification obligation

Name

Oxford technology 2 VCT Plc

City of registered office (if applicable)

Oxford

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

 
  Name                            City of registered office    Country of registered office 
   Oxford Technology 2 VCT plc     Oxford                       UK 
                                ===========================  ============================== 
 

5. Date on which the threshold was crossed or reached

04-Aug-2022

6. Date on which Issuer notified

05-Aug-2022

7. Total positions of person(s) subject to the notification obligation

 
                          % of voting rights      % of voting rights      Total of both in %      Total number of 
                          attached to shares      through financial       (8.A + 8.B)             voting rights held 
                          (total of 8.A)          instruments (total                              in issuer 
                                                  of 8.B 1 + 8.B 2) 
   Resulting situation 
    on the date on 
    which threshold 
    was crossed or 
    reached             5.208085                   0.000000                5.208085             1587776 
                        ======================  ======================  ======================  ====================== 
   Position of 
    previous 
    notification (if 
    applicable)                                    0.000000 
                        ======================  ======================  ======================  ====================== 
 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

 
Class/Type           Number of direct voting  Number of indirect      % of direct voting       % of indirect voting 
 of shares ISIN      rights (DTR5.1)          voting rights           rights (DTR5.1)          rights (DTR5.2.1) 
 code(if possible)                            (DTR5.2.1) 
GB00BMWLM973                                  1587776                                          5.208085 % 
                     =======================  ======================  =======================  ======================= 
Sub Total 8.A           1587776                                       5.208085 % 
                     ===============================================  ================================================ 
 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 
Type of financial  Expiration date  Exercise/conversion period  Number of voting rights that may    % of voting rights 
 instrument                                                     be acquired if the instrument is 
                                                                exercised/converted 
 
Sub Total 8.B1 
                   ===========================================  ==================================  ================== 
 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

 
Type of         Expiration date  Exercise/conversion   Physical or cash      Number of voting       % of voting rights 
 financial                       period                settlement            rights 
 instrument 
 
Sub Total 8.B2 
                ===========================================================  =====================  ================== 
 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

 
Ultimate      Name of controlled         % of voting rights if it  % of voting rights        Total of both if it 
 controlling  undertaking                equals or is higher than  through financial         equals or is higher than 
 person                                  the notifiable threshold  instruments if it equals  the notifiable threshold 
                                                                   or is higher than the 
                                                                   notifiable 
                                                                   threshold 
 
 

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

05-Aug-2022

13. Place Of Completion

Oxford, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUVUSRUBUWRAR

(END) Dow Jones Newswires

August 05, 2022 10:33 ET (14:33 GMT)

Arecor Therapeutics (LSE:AREC)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Arecor Therapeutics Charts.
Arecor Therapeutics (LSE:AREC)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Arecor Therapeutics Charts.